







【 一般講演 1 】
K-Ras/JNK 経路の抑制は膵癌幹細胞を除去し膵癌腫
瘍形成を抑制する
○岡田雅司 1、澁谷慶太 1,5、 佐藤　篤 1,2、鈴木
修平 1,3、清野　学 1,4、北中千史 1,5,6
（1 山形大学医学部・腫瘍分子医科学講座、 2 脳













　In vitro において、JNK を特異的阻害薬である
SP600125 による薬理学的処理、もしくは JNK に対
する siRNA を用いて抑制すると、膵癌幹細胞の幹
細胞性が失われ、腫瘍形成も抑制された。また、in 


















【 一般講演 2 】
Apurinic/apyrimidinic endonuclease1/redox 
factor-1 (Ape1/Ref-1) modulates T cell response 
through its redox function
○ Akhter Nasrin1, Yuji Takeda1, Hidetoshi 
Nara1, Akemi Araki1, Naoto Ishii2 and 
Hironobu Asao1 
(1Department of Immunology, Yamagata 
University Faculty of Medicine,
2Department of Immunology, Tohoku 
University Graduate School of Medicine)
【Background and Purpose】Ape1/Ref-1, which is 
a multifunctional protein possessing DNA repair, 
redox control and transcriptional regulatory 
activities, has an important role in controlling 
cellular response to oxidative stress. T cell immune 
responses are essential for various pathological 
infections and inflammations in oxidative 
conditions. Many studies have discussed the T cell 
response during oxidative stress. However, the 
function of Ape1/Ref-1 in T cell immune responses 
is not well investigated. In the present study, we 
analyzed the role of redox function of Ape1/Ref-1 
in T cell activation.
【Methods and Results】Mouse whole splenocytes 
were stimulated with lectin, Concanavalin A (ConA) 
for 3 days in the presence or absence of E3330, 
which is an specific inhibitor of Ape1/Ref-1 redox 
activity. IFN-γ-producing cells were assessed by 
intracellular staining and flowcytometry analysis. 
E3330 enhanced IFN-γ-producing CD4+ T cells 
upon ConA stimulation. To confirm this result, 
splenocytes from ovalbumin (OVA)-specific TCR-
expressing OT-II transgenic mice were stimulated 
with OVA in the presence or absence of E3330. 
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E3330 again enhanced IFN-γ-producing OVA-
specific CD4+ T cells. 
Next, we examined whether E3330 modulates the 
function of CD4+ T cells or antigen presenting 
cells (APC). E3330-pretreated OVA-pulsed bone 
marrow-derived dendritic cells up-regulated IFN-
γ-producing OT-II T cells. This result suggested 
that E3330 enhanced Th1 response through the 
alteration of APC function. Then we assessed the 
surface expression of MHC-II and co-stimulatory 
molecules: CD80 and CD86 on APC in the presence 
or absence of E3330. However, we did not find any 
significant difference of the surface expression of 
these molecules in the presence or absence of E3330. 
Now we focus on several cytokines that mediate 
CD4+ T cell differentiation as 3rd signals from 
APC.
【Conclusions】 Our findings suggest that the redox 
function of Ape1/Ref-1 is a modulator of T cell 
activation and may inhibit Th1 cell differentiation 
through the modification of APC.
 
【 一般講演 3 】
SOD1 欠損マウスにおける脂肪肝形成の分子機構
○李在勇 1、姜恩實 1、倉橋敏裕 1、本間拓二郎 1、





















断・活性化に働く protease である S1P・S2P は、小
胞体ストレスの際に Unfolded Protein Response に
働く遺伝子の発現調節を担う転写調節因子の ATF6
を切断・活性化する酵素と同一であるため、小胞体ス


















【 一般講演 4 】
H i g h - m o b i l i t y  G r o u p  B o x  1  A t t e n u a t e s 
Mitochondrial Dysfunction and Apoptosis via Heat 
Shock Protein Beta 1 Induction in Doxorubicin-
induced Cardiomyopathy
○ Taro Narumi, Tetsuro Shishido, Shinpei 
Kadowaki, Yuki Honda, Miyuki Yokoyama, 
Daisuke Kinoshita, Tetsuya Takahashi, 
Tetsu Watanabe, Isao Kubota
（Department of Cardiology, Pulmonology, 
and Nephrology, Yamagata University 
School of Medicine）
Abstract
Aims:  The apoptosis of cardiomyocytes is believed 
to account for the cardiotoxicity of doxorubicin. 
Cardiomyocyte apoptosis contributes to loss of 
myocardial tissue and contractile dysfunction. 
Given that high-mobility group box 1 (HMGB1) is a 
nuclear DNA-binding protein capable of inhibiting 
apoptosis, we aimed to clarify the role of HMGB1 
on heat shock protein beta 1 (HSPB1) expressions 
during doxorubicin-induced cardiomyopathy.
Methods and Results:  Overexpression of HMGB1 
extremely enhanced heat shock element promoter 
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activity. Furthermore, overexpression of HMGB1 
increased the binding of HMGB1 to heat shock 
factor 2. As a result, transfection with HMGB1 
increased the expression of HSPB1 at the protein 
and mRNA levels, and inhibited mitochondrial 
dysfunction and apoptosis after exposure of 
cardiomyocytes to doxorubicin. Silencing of HSPB1 
abrogated the inhibitory effect of HMGB1 against 
cardiomyocyte apoptosis. To investigate these 
effects in vivo, doxorubicin was administrated 
to both transgenic mice with cardiac-specific 
overexpression of HMGB1 (HMGB1-Tg) as well 
as to their wild-type littermates (WT). Levels of 
HSPB1 after doxorubicin administration were 
significantly higher in HMGB1-Tg mice than in 
WT mice. The mitochondrial damage observed 
in doxorubicin-treated WT mice were suppressed 
in  doxorubic in-treated HMGB-1 Tg mice . 
Cardiomyocyte dysfunction after doxorubicin 
administration was attenuated in HMGB1-Tg mice 
compared with WT-mice. As a result, the survival 
rate after doxorubicin administration was higher 
for of HMGB1-Tg mice than for WT mice. 
Conclusions:  We report the first in vivo and in 
vitro evidence that cardiac HMGB1 attenuates 
mitochondrial dysfunction and cardiomyocyte 
apoptosis associated with doxorubicin-induced 
cardiomyopathy through induction of HSPB1 
expressions.
 
【 一般講演 5 】
マウス圧迫創における HMGB1 陽性細胞分布の特徴










ト上重要な因子として近年注目される High Mobility 





【方法】6 週齢の JCL/ICR 雄性マウスを用いた。褥
瘡を模した圧迫創はネオジム磁石 2 つを用い 1 つは腹
腔内、もう 1 つは腰背部の皮膚側から装着し深部骨
格筋を含む皮膚全層を 6 時間圧迫後に再度麻酔下で




【結果】肉眼的所見として、1 ～ 2 日目は蒼白 3 ～ 5























































よび罨法施行後 24 時間、72 時間にそれぞれ耳介静脈









































　Rota-rod test では，被験体は 10 週齢のウィスター
系雄性ラットを用いた．被験体の飼育環境は22±2℃，
































【 一般講演 8 】
ALA 合成酵素遺伝子破壊マウスヘテロ接合体に対す
るマウス用トレッドミルを用いた運動持久力の解析
○野原豪和 1, 斉藤真一 1, 中野　博 1, 村上綾子
1, 白澤信行 2, 高橋　究 3, 田中　徹 3, 中島元夫 3, 
中島　修 1
（1 山形大学医学部遺伝子実験センター , 2 山形








































































なるが、1 台 50 万円以上と高額である。動物実験セ
ンターでは SPF エリアとクリーンエリアにイソフル

























成分 商品名 用途 製造販売元 製品濃度
































0.15 ～ 0.3 mg/Kg
ドルミカム
2.0 ～ 4.0 mg/Kg
ベトルファール




































マウス体重 (g) 10.0 20.0 30.0 40.0
投与量 (ml) 0.05 0.10 0.15 0.20
ラット体重 (g) 100 200 300 400












































ターに届いた場合は 2 階実験者入口や 1 階の集中監視
室前等に掲示するので、積極的に利用いただきたい。
　また、動物実験についてのご相談、実験動物や飼育
機器などに関する質問等、ご不明な点はセンター職員
に問い合わせ願いたい。
